Sex |
Male |
56 (48) |
Female |
61 (52) |
Primary gastric cancer location |
Antral part |
16 (13.7) |
Corpus |
44 (37.6) |
Proximal part |
1 (0.9) |
Antral part + corpus |
26 (22.2) |
Corpus + proximal part |
2 (1.7) |
Subtotal or total lesion |
24 (20.5) |
Unknown |
4 (3.4) |
Tumour histology |
G2 |
8 (6.8) |
G3 |
25 (21.4) |
G4 |
48 (41) |
Signet ring cell |
24 (20.5) |
Mucinous |
5 (4.3) |
Other |
1 (0.9) |
Unknown |
6 (5.1) |
Curative group (n = 70) |
|
|
Stage of peritoneal carcinomatosis according to Japanese classification (JGCA) |
P0 (CY1) |
4 (5.7) |
P1 |
28 (40) |
P2 |
31 (44.3) |
P3 |
7 (10) |
Peritoneal cancer index, points |
0‐6 |
49 (70) |
7‐12 |
13 (18.6) |
13 and more |
7 (10) |
Unknown |
1 (1.4) |
Mean peritoneal cancer index, points |
5,6 ± 3,6 (0‐19) |
|
Ascites |
Present |
3 (4.3) |
Absent |
67 (95.7) |
pT (TNM 7, 2009) |
pT4a |
54 (77.2) |
pT4b |
15 (21.4) |
Unknown |
1 (1.4) |
pN |
pN0 |
15 (21.4) |
pN+ |
38 (54.3) |
Unknown |
17 (24.3) |
Completeness of cytoreduction score |
CC‐0 |
50 (71.4) |
CC‐1 |
15 (21.4) |
CC‐2,3 |
5 (7.2) |
Postoperative systemic chemotherapy |
Yes |
44 (62.9) |
No |
17 (24.3) |
Unknown |
9 (12.8) |
Adjuvant group (n = 37) |
|
|
pT (TNM 7, 2009) |
pT4a |
29 (78.4) |
pT4b |
8 (21.6) |
Total circular tumor infiltration of stomach serous membrane |
Present |
10 (27) |
Absent |
27 (73) |
pN |
pN0 |
12 (32.4) |
pN+ |
24 (64.9) |
Unknown |
1 (2.7) |
Stage (TNM 7, 2009) |
IIB |
10 (27) |
IIIA |
2 (5.4) |
IIIB |
12 (32.4) |
IIIC |
13 (35.2) |
Postoperative systemic chemotherapy |
Yes |
8 (21.6) |
No |
28 (75.7) |
Unknown |
1 (2.7) |
Palliative group (n = 10) |
|
|
Mean volume of ascitic fluid, litres |
5,5 ± 1,4 (3,5‐8) |
|
Mean peritoneal cancer index, points |
30,6 ± 6,1 (15‐39) |
|